{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:18:56Z","timestamp":1785853136031,"version":"3.56.0"},"reference-count":77,"publisher":"Elsevier","isbn-type":[{"value":"9780443343858","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007871","name":"European College of Neuropsychopharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["320030\\u2013204978"],"award-info":[{"award-number":["320030\\u2013204978"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.irn.2025.02.005","type":"book-chapter","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T20:25:20Z","timestamp":1742243120000},"page":"203-230","source":"Crossref","is-referenced-by-count":3,"title":["Molecular brain imaging of psychedelic action"],"prefix":"10.1016","author":[{"given":"Paul","family":"Cumming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Egger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte M.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/bs.irn.2025.02.005_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0028-3908(76)90102-7","article-title":"LSD and 2-bromo-LSD: Comparison on effects on serotonergic neurones and on neurones in two serotonergic projection areas, the ventral lateral geniculate and amygdala","volume":"15","author":"Aghajanian","year":"1976","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.irn.2025.02.005_bib2","article-title":"Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: A controlled trial in healthy subjects","volume":"14","author":"Aicher","year":"2023","journal-title":"Front Psychiatry"},{"issue":"8","key":"10.1016\/bs.irn.2025.02.005_bib3","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00259-021-05282-7","article-title":"Clinical performance of long axial field of view PET\/CT: A head-to-head intra-individual comparison of the biograph vision Quadra with the biograph vision PET\/CT","volume":"48","author":"Alberts","year":"2021","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"4","key":"10.1016\/bs.irn.2025.02.005_bib4","first-page":"288","article-title":"99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): Basic kinetic studies of a tracer of cerebral blood flow","volume":"1","author":"Andersen","year":"1989","journal-title":"Cerebrovascular and Brain Metabolism Reviews"},{"key":"10.1016\/bs.irn.2025.02.005_bib5","article-title":"Human cortical serotonin 2A receptor occupancy by psilocybin measured using [(11)C]MDL 100,907 dynamic PET and a resting-state fMRI-based brain parcellation","volume":"2","author":"Barrett","year":"2021","journal-title":"Front Neuroergonomics"},{"issue":"1","key":"10.1016\/bs.irn.2025.02.005_bib6","first-page":"120","article-title":"A high-resolution in vivo Atlas of the human brain\u2019s serotonin system","volume":"37","author":"Beliveau","year":"2017","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2025.02.005_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.886408","article-title":"Monoamine oxidase inhibition by plant-derived \u03b2-carbolines; implications for the psychopharmacology of Tobacco and Ayahuasca","volume":"13","author":"Berlowitz","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2025.02.005_bib8","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.neuroimage.2009.05.040","article-title":"Subcortical elevation of metabolism in Parkinson\u2019s disease--a critical reappraisal in the context of global mean normalization","volume":"47","author":"Borghammer","year":"2009","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/bs.irn.2025.02.005_bib9","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0026-895X(25)09519-7","article-title":"3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor","volume":"38","author":"Branchek","year":"1990","journal-title":"Molecular Pharmacology"},{"issue":"6","key":"10.1016\/bs.irn.2025.02.005_bib10","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"10.1016\/bs.irn.2025.02.005_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26092451","article-title":"Molecular and functional imaging studies of psychedelic drug action in animals and humans","volume":"26","author":"Cumming","year":"2021","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/bs.irn.2025.02.005_bib12","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00004647-200205000-00011","article-title":"Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein","volume":"22","author":"Cumming","year":"2002","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"issue":"Pt A","key":"10.1016\/bs.irn.2025.02.005_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.phrs.2016.08.022","article-title":"The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT(1A), D(2) and TAAR(1) receptors","volume":"113","author":"De Gregorio","year":"2016","journal-title":"Pharmacological Research: the Official Journal of the Italian Pharmacological Society"},{"key":"10.1016\/bs.irn.2025.02.005_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2020.11.013","article-title":"Effects of a single dose of psilocybin on behaviour, brain 5-HT(2A) receptor occupancy and gene expression in the pig","volume":"42","author":"Donovan","year":"2021","journal-title":"European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/bs.irn.2025.02.005_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0024-3205(79)90210-8","article-title":"Pharmacological characterization of 3H-LSD binding sites in mouse brain in vivo","volume":"24","author":"Duchemin","year":"1979","journal-title":"Life Sciences"},{"key":"10.1016\/bs.irn.2025.02.005_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1140656","article-title":"A pilot study of cerebral metabolism and serotonin 5-HT(2A) receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine","volume":"14","author":"Egger","year":"2023","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.irn.2025.02.005_bib17","article-title":"Serotonin 5-HT(2A), 5-HT(2c) and 5-HT(1A) receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response","volume":"154","author":"Erkizia-Santamar\u00eda","year":"2022","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"6","key":"10.1016\/bs.irn.2025.02.005_bib18","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1001\/archgenpsychiatry.2011.56","article-title":"In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or \u201cecstasy\u201d) and hallucinogen users","volume":"68","author":"Erritzoe","year":"2011","journal-title":"Archives of General Psychiatry"},{"issue":"12","key":"10.1016\/bs.irn.2025.02.005_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.biopsych.2022.10.012","article-title":"Brain serotonin release is reduced in patients with depression: A [(11)C]Cimbi-36 positron emission tomography study with a d-amphetamine challenge","volume":"93","author":"Erritzoe","year":"2023","journal-title":"Biological Psychiatry"},{"issue":"7","key":"10.1016\/bs.irn.2025.02.005_bib20","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/jcbfm.2014.68","article-title":"Serotonin 2A receptor agonist binding in the human brain with [\u00b9\u00b9C]Cimbi-36","volume":"34","author":"Ettrup","year":"2014","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"issue":"3","key":"10.1016\/bs.irn.2025.02.005_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1528-1157.1969.tb03853.x","article-title":"Psychosis and temporal lobe epilepsy. A controlled investigation","volume":"10","author":"Flor-Henry","year":"1969","journal-title":"Epilepsia"},{"issue":"3307","key":"10.1016\/bs.irn.2025.02.005_bib22","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1126\/science.127.3307.1173","article-title":"Patterns of tolerance to lysergic acid diethylamide and mescaline in rats","volume":"127","author":"Freedman","year":"1958","journal-title":"Science"},{"issue":"3","key":"10.1016\/bs.irn.2025.02.005_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0024-3205(98)00262-8","article-title":"Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro","volume":"63","author":"Giacomelli","year":"1998","journal-title":"Life Sciences"},{"issue":"3","key":"10.1016\/bs.irn.2025.02.005_bib24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF01922567","article-title":"Lysergic acid diethylamide affects blood flow to specific areas of the conscious rat brain","volume":"31","author":"Goldman","year":"1975","journal-title":"Experientia"},{"issue":"6","key":"10.1016\/bs.irn.2025.02.005_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0893-133X(98)00089-X","article-title":"Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG","volume":"20","author":"Gouzoulis-Mayfrank","year":"1999","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/bs.irn.2025.02.005_bib26","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/sj.npp.1300711","article-title":"Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex","volume":"30","author":"Gresch","year":"2005","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.02.005_bib27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1471-4159.1986.tb12933.x","article-title":"Local cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists","volume":"46","author":"Grome","year":"1986","journal-title":"Journal of Neurochemistry"},{"issue":"4","key":"10.1016\/bs.irn.2025.02.005_bib28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00213-011-2616-6","article-title":"Behavioral effects of \u03b1,\u03b1,\u03b2,\u03b2-tetradeutero-5-MeO-DMT in rats: Comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor","volume":"221","author":"Halberstadt","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.irn.2025.02.005_bib29","unstructured":"Hasler, F., Quednow, B.B., Treyer, V., Schubiger, P.A., Buck, A., & Vollenweider, F.X. (2009 March 25\u201326, 2009). Role of prefrontal serotonin-2A receptors in self experience during psilocybin induced altered states Swiss Society of Sleep Research, Sleep Medicine and Chronobiology (SSSSC) and the Swiss Society of Biological Psychiatry (SSBP), Bern."},{"issue":"11","key":"10.1016\/bs.irn.2025.02.005_bib30","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0006-3223(92)90059-9","article-title":"Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research","volume":"32","author":"Hermle","year":"1992","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2025.02.005_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1471-4159.1987.tb13135.x","article-title":"N1-methyl-2-125I-lysergic acid diethylamide, a preferred ligand for in vitro and in vivo characterization of serotonin receptors","volume":"48","author":"Hoffman","year":"1987","journal-title":"Journal of Neurochemistry"},{"issue":"11","key":"10.1016\/bs.irn.2025.02.005_bib32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF02157368","article-title":"The effect of LSD-25 upon the cerebral blood flow and EEG in cats","volume":"12","author":"Ingvar","year":"1956","journal-title":"Experientia"},{"issue":"2","key":"10.1016\/bs.irn.2025.02.005_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/0271678X16629483","article-title":"Cerebral 5-HT release correlates with [(11)C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain","volume":"37","author":"J\u00f8rgensen","year":"2017","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/bs.irn.2025.02.005_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2019.03.021","article-title":"Reduced serotonin receptors and transporters in normal aging adults: A meta-analysis of PET and SPECT imaging studies","volume":"80","author":"Karrer","year":"2019","journal-title":"Neurobiology of Aging"},{"issue":"12","key":"10.1016\/bs.irn.2025.02.005_bib35","first-page":"2266","article-title":"Fluorine-18-altanserin: A radioligand for the study of serotonin receptors with PET: Radiolabeling and in vivo biologic behavior in rats","volume":"32","author":"Lemaire","year":"1991","journal-title":"Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2025.02.005_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112203","article-title":"A non-hallucinogenic LSD analog with therapeutic potential for mood disorders","volume":"42","author":"Lewis","year":"2023","journal-title":"Cell Reports"},{"key":"10.1016\/bs.irn.2025.02.005_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroimage.2017.07.020","article-title":"Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow","volume":"159","author":"Lewis","year":"2017","journal-title":"NeuroImage"},{"issue":"2","key":"10.1016\/bs.irn.2025.02.005_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1124\/jpet.109.157560","article-title":"Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats","volume":"331","author":"Li","year":"2009","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/bs.irn.2025.02.005_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2015.01.001","article-title":"Trace amine-associated receptors: Ligands, neural circuits, and behaviors","volume":"34","author":"Liberles","year":"2015","journal-title":"Current Opinion in Neurobiology"},{"issue":"8","key":"10.1016\/bs.irn.2025.02.005_bib40","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.nucmedbio.2011.04.006","article-title":"Mass dose effects and in vivo affinity in brain PET receptor studies--a study of cerebral 5-HT4 receptor binding with [11C]SB207145","volume":"38","author":"Madsen","year":"2011","journal-title":"Nuclear Medicine and Biology"},{"issue":"7","key":"10.1016\/bs.irn.2025.02.005_bib41","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2025.02.005_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.euroneuro.2020.02.001","article-title":"A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding","volume":"33","author":"Madsen","year":"2020","journal-title":"European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology"},{"key":"10.1016\/bs.irn.2025.02.005_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.euroneuro.2022.10.008","article-title":"Ayahuasca\u2019s therapeutic potential: What we know - and what not","volume":"66","author":"Maia","year":"2023","journal-title":"European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2025.02.005_bib44","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF02245809","article-title":"Complex stimulus properties of LSD: A drug discrimination study with alpha 2-adrenoceptor agonists and antagonists","volume":"120","author":"Marona-Lewicka","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/bs.irn.2025.02.005_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/02698811211026454","article-title":"Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals","volume":"36","author":"McCulloch","year":"2022","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.02.005_bib46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0893-133X(89)90010-9","article-title":"Chronic treatment with (+\/-)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain","volume":"2","author":"McKenna","year":"1989","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"6-7","key":"10.1016\/bs.irn.2025.02.005_bib47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neuint.2010.01.010","article-title":"Agonist binding fraction of dopamine D2\/3 receptors in rat brain: A quantitative autoradiographic study","volume":"56","author":"Minuzzi","year":"2010","journal-title":"Neurochemistry International"},{"issue":"4","key":"10.1016\/bs.irn.2025.02.005_bib48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/syn.20141","article-title":"Interaction between LSD and dopamine D2\/3 binding sites in pig brain","volume":"56","author":"Minuzzi","year":"2005","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/bs.irn.2025.02.005_bib49","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2967\/jnumed.109.072314","article-title":"Side effects profile in humans of (11)C-(+)-PHNO, a dopamine D(2\/3) agonist ligand for PET","volume":"51","author":"Mizrahi","year":"2010","journal-title":"Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine"},{"issue":"6","key":"10.1016\/bs.irn.2025.02.005_bib50","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nature Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2025.02.005_bib51","first-page":"4","article-title":"The neurobiology of cocaine addiction","volume":"3","author":"Nestler","year":"2005","journal-title":"Science & Practice Perspectives \/ a Publication of the National Institute on Drug Abuse, National Institutes of Health"},{"issue":"4","key":"10.1016\/bs.irn.2025.02.005_bib52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/a-1310-3990","article-title":"The history of psychedelics in psychiatry","volume":"54","author":"Nichols","year":"2021","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2025.02.005_bib53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.euroneuro.2016.11.013","article-title":"Inverse agonists - what do they mean for psychiatry?","volume":"27","author":"Nutt","year":"2017","journal-title":"European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2025.02.005_bib54","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/syn.20706","article-title":"MDMA-evoked changes in the binding of dopamine D(2) receptor ligands in striatum of rats with unilateral serotonin depletion","volume":"64","author":"Ostergaard","year":"2010","journal-title":"Synapse"},{"issue":"8","key":"10.1016\/bs.irn.2025.02.005_bib55","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.WCB.0000074092.59115.23","article-title":"Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus\/infusion approach","volume":"23","author":"Pinborg","year":"2003","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"issue":"4","key":"10.1016\/bs.irn.2025.02.005_bib56","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1016\/j.neuroimage.2011.09.045","article-title":"Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography","volume":"59","author":"Quednow","year":"2012","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/bs.irn.2025.02.005_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020835","article-title":"A single dose of psilocybin increases synaptic density and decreases 5-HT(2A) receptor density in the pig brain","volume":"22","author":"Raval","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2025.02.005_bib58","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuropharm.2015.08.034","article-title":"Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)","volume":"99","author":"Rickli","year":"2015","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/bs.irn.2025.02.005_bib59","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/syn.20053","article-title":"MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain","volume":"53","author":"Rosa-Neto","year":"2004","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/bs.irn.2025.02.005_bib60","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1248\/bpb.b14-00315","article-title":"Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats","volume":"38","author":"Sakashita","year":"2015","journal-title":"Biological & Pharmaceutical Bulletin"},{"issue":"1","key":"10.1016\/bs.irn.2025.02.005_bib61","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/JCP.0000000000000436","article-title":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A SPECT study","volume":"36","author":"Sanches","year":"2016","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2025.02.005_bib62","first-page":"243","article-title":"A potential new brain-scanning agent: 4-77Br-2,5-dimethoxyphenylisoproplamine (4-Br-DPIA)","volume":"16","author":"Sargent","year":"1975","journal-title":"Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine"},{"issue":"9","key":"10.1016\/bs.irn.2025.02.005_bib63","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0028-3908(92)90126-A","article-title":"Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors","volume":"31","author":"Scheffel","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.irn.2025.02.005_bib64","article-title":"Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience","author":"Singleton","year":"2023","journal-title":"bioRxiv"},{"issue":"3","key":"10.1016\/bs.irn.2025.02.005_bib65","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1749-6632.1957.tb40742.x","article-title":"The effects of D-lysergic acid diethylamide on cerebral circulation and overall metabolism","volume":"66","author":"Sokoloff","year":"1957","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"4","key":"10.1016\/bs.irn.2025.02.005_bib66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881120959609","article-title":"Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans","volume":"35","author":"Stenb\u00e6k","year":"2021","journal-title":"Journal of Psychopharmacology"},{"issue":"22","key":"10.1016\/bs.irn.2025.02.005_bib67","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/0024-3205(79)90078-X","article-title":"Alterations of serotonin and LSD receptor binding following repeated administration of LSD","volume":"24","author":"Trulson","year":"1979","journal-title":"Life Sciences"},{"issue":"11","key":"10.1016\/bs.irn.2025.02.005_bib68","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0028-3908(77)90135-6","article-title":"Lack of tolerance to the depression of raphe unit activity by lysergic acid diethylamide","volume":"16","author":"Trulson","year":"1977","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/bs.irn.2025.02.005_bib69","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0893-133X(96)00246-1","article-title":"Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis","volume":"16","author":"Vollenweider","year":"1997","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2025.02.005_bib70","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0925-4927(98)00033-X","article-title":"Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET)","volume":"83","author":"Vollenweider","year":"1998","journal-title":"Psychiatry Research"},{"issue":"5","key":"10.1016\/bs.irn.2025.02.005_bib71","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0893-133X(98)00108-0","article-title":"5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride","volume":"20","author":"Vollenweider","year":"1999","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/bs.irn.2025.02.005_bib72","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/BF02984655","article-title":"PET kinetic analysis--compartmental model","volume":"20","author":"Watabe","year":"2006","journal-title":"Annals of Nuclear Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2025.02.005_bib73","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/syn.890010502","article-title":"Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD","volume":"1","author":"Wong","year":"1987","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/bs.irn.2025.02.005_bib74","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13550-022-00915-w","article-title":"Toward in vivo proof of binding of (18)F-labeled inhibitor [(18)F]TRACK to peripheral tropomyosin receptor kinases","volume":"12","author":"Wuest","year":"2022","journal-title":"EJNMMI Research"},{"issue":"5","key":"10.1016\/bs.irn.2025.02.005_bib75","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0969-8051(02)00306-2","article-title":"Pharmacokinetics and brain distribution in non human primate of R(-)[123I]DOI, A 5HT(2A\/2C) serotonin agonist","volume":"29","author":"Zea-Ponce","year":"2002","journal-title":"Nuclear Medicine and Biology"},{"issue":"8","key":"10.1016\/bs.irn.2025.02.005_bib76","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jcbfm.2014.92","article-title":"Comparison of cerebral blood flow acquired by simultaneous [15O]water positron emission tomography and arterial spin labeling magnetic resonance imaging","volume":"34","author":"Zhang","year":"2014","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"issue":"1","key":"10.1016\/bs.irn.2025.02.005_bib77","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1021\/acs.jmedchem.7b01245","article-title":"Discovery of 7-[(18)F]fluorotryptophan as a novel positron emission tomography (PET) probe for the visualization of tryptophan metabolism in vivo","volume":"61","author":"Zlatopolskiy","year":"2018","journal-title":"Journal of Medicinal Chemistry"}],"container-title":["International Review of Neurobiology","Psychedelics in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774225000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T22:52:56Z","timestamp":1750287176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774225000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443343858"],"references-count":77,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2025.02.005","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}